Concepedia

Helen Reynolds

HR

Statistics

Publications

29

Citations

2.5K

H-Index

21

Active since

1984

Affiliations

University of Liverpool(Current)

Liverpool School of Tropical Medicine

University of Cape Town

Makerere University

Infectious Diseases Institute

Helen Reynolds is an author at University of Liverpool specializing in antiviral therapy, antiretroviral therapy, and antiviral pharmacology.

ORCID

Publications per year

1984–2023

29

Publications

29

Oral versus Intravenous Antibiotics for Bone and Joint Infection

Ho Kwong Li, Ines Rombach, Rhea Zambellas et al. · New England Journal of Medicine · 2019 · 900 citations · Full text

, , +14

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Guy Thwaites, Matthew Scarborough, Alexander J. Szubert et al. · The Lancet · 2017 · 187 citations · Full text

, , +17

The pharmacokinetics of methadone in HIV‐positive patients receiving the non‐nucleoside reverse transcriptase inhibitor efavirenz

Fiona Mulcahy, John Tjia, Helen Reynolds et al. · British Journal of Clinical Pharmacology · 2001 · 153 citations · Full text

, , +16

Dolutegravir versus efavirenz in women starting HIV therapy in late pregnancy (DolPHIN-2): an open-label, randomised controlled trial

Kenneth Kintu, Thokozile R. Malaba, Jesca Nakibuka et al. · The Lancet HIV · 2020 · 125 citations · Full text

, , +16

Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study

Saye Khoo, Richard J. Fitzgerald, Sean Ewings et al. · Journal of Antimicrobial Chemotherapy · 2021 · 118 citations · Full text

, , +13

1–5 of 29